Abstract |
Use of terlipressin in septic shock relies on a series of European studies resulting in a better knowledge of this vasopressive agent. Additional studies demonstrate that this agent appears to have attractive properties when administered properly. In comparison to prior reports, continuous infusion of low-dose terlipressin seems superior when administered to septic animals. For the first time in humans, Morelli and colleagues compared this mode of administration with other vasopressors.
|
Authors | Marc Leone |
Journal | Critical care (London, England)
(Crit Care)
Vol. 13
Issue 5
Pg. 192
( 2009)
ISSN: 1466-609X [Electronic] England |
PMID | 19832999
(Publication Type: Journal Article, Comment)
|
Chemical References |
- Vasoconstrictor Agents
- Lypressin
- Terlipressin
|
Topics |
- Humans
- Lypressin
(administration & dosage, analogs & derivatives, pharmacology, therapeutic use)
- Shock, Septic
(drug therapy)
- Terlipressin
- Vasoconstrictor Agents
(administration & dosage, pharmacology, therapeutic use)
|